Real‐world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health system
Abstract Background We evaluated the frequency of genomic testing and treatment patterns by age category in patients with newly diagnosed (ND) acute myeloid leukemia (AML) treated in both academic‐ and community‐based health systems within a single Midwestern State. Methods Retrospective analysis of...
Main Authors: | John C. Byrd, Jennifer L. Gatz, Cynthia Lim Louis, Alice S. Mims, Uma Borate, Ashley O. Yocum, Theophilus J. Gana, Amy Burd |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6442 |
Similar Items
-
Disparities in mortality among acute myeloid leukemia‐related hospitalizations
by: Sara Taveras Alam, et al.
Published: (2023-02-01) -
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
by: Sylvain Garciaz, et al.
Published: (2022-04-01) -
Cytokines profiling as prognostic markers in newly diagnosed acute myeloid leukemia
by: Hiba Shakir Ahmed, et al.
Published: (2017-01-01) -
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities
by: Gaku Oshikawa, et al.
Published: (2023-04-01) -
A precision medicine classification for treatment of acute myeloid leukemia in older patients
by: Alice S. Mims, et al.
Published: (2021-06-01)